Go Deep
enVVeno Medical Corporation
enVVeno Medical Corporation Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,733 | -0.3 | 0.27 | 0.02 | 750.62 |
| Oct 2026 | 22,823 | -0.3 | 0.25 | 0.02 | 707.52 |
| Oct 2026 | 22,779 | -0.3 | 0.26 | 0.02 | 729.14 |
| Oct 2026 | 22,777 | -0.3 | 0.26 | 0.02 | 730.09 |
| Oct 2026 | 22,837 | -0.3 | 0.25 | 0.02 | 693.29 |
| Oct 2026 | 22,894 | -0.3 | 0.23 | 0.02 | 652.24 |
enVVeno Medical Corporation Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -3,600,000.0 | -3,849,000.0 | -3,736,000.0 | -4,539,000.0 |
| EPS | -5.4 | -5.9 | — | -8.1 |
enVVeno Medical Corporation Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Net Profit | -19,472,000.0 | -21,819,000.0 | -23,516,000.0 | -24,669,000.0 | — |
| EPS | -33.1 | -44.5 | -66.8 | -77.0 | — |
enVVeno Medical Corporation Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 29,562,000.0 | 44,954,000.0 | 48,635,000.0 | 41,661,000.0 | — |
| Total Liabilities | 2,432,000.0 | 2,795,000.0 | 2,435,000.0 | 2,932,000.0 | — |
| Total Equity | 27,130,000.0 | 42,159,000.0 | 46,200,000.0 | 38,729,000.0 | — |
Owes vs Owns
enVVeno Medical Corporation owed $0.09 for every $1 it owned in Jun 2026, up from $0.07 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.09× | 0.08× | 0.06× | 0.05× | 0.07× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
enVVeno Medical Corporation Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 95.4%Fixed assets (tangible) 2.4%Other assets 2.2%
How it's funded — Dec 2025
Short-term debt 1.3%Long-term debt 1.0%Payables 1.2%Other liabilities 4.6%Shareholders' equity 91.8%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 28.2 | 43.2 | 46.4 | 39.0 |
| Receivables | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.7 | 1.2 | 1.7 | 2.2 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 0.6 | 0.6 | 0.5 | 0.4 |
| Liabilities & equity | ||||
| Short-term debt | 0.4 | 0.4 | 0.3 | 0.3 |
| Long-term debt | 0.3 | 0.7 | 1.1 | 1.4 |
| Payables | 0.4 | 1.0 | 0.4 | 0.6 |
| Other liabilities | 1.4 | 0.7 | 0.6 | 0.6 |
| Shareholders' equity | 27.1 | 42.2 | 46.2 | 38.7 |
| Net tangible assets | 27.1 | 42.2 | 46.2 | 38.7 |
enVVeno Medical Corporation Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -15,568,000.0 | -16,838,000.0 | -18,858,000.0 | -15,619,000.0 | — |
| Investing Activities | 15,856,000.0 | 1,335,000.0 | -7,868,000.0 | -34,554,000.0 | — |
| Financing Activities | 1,023,000.0 | 13,637,000.0 | 25,791,000.0 | 0.0 | — |